Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

COX inhibition for tocolysis and its effect on the neonate

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cordero L, Nankervis CA, Gardner D, Giannone PJ . The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. J Perinatol 2007; 27: 22–27.

    Article  CAS  Google Scholar 

  2. Balasubramaniam J . Nimesulide and neonatal renal failure. Lancet 2000; 355 (9203): 575.

    Article  CAS  Google Scholar 

  3. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R . Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 1999; 354 (9190): 1615.

    Article  CAS  Google Scholar 

  4. Kramer BK . Renal effects of cyclo-oxygenase-type-2 inhibition. Lancet 2000; 355 (9199): 236–237.

    Article  CAS  Google Scholar 

  5. Balasubramaniam J . Selective COX-2 inhibitors and nephrotoxicity. Am J Kidney Dis 2000; 36 (3): 675–676.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balasubramaniam, J. COX inhibition for tocolysis and its effect on the neonate. J Perinatol 27, 395 (2007). https://doi.org/10.1038/sj.jp.7211744

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211744

Search

Quick links